{"schema_version":"secwatch.filing_event.v1","accession":"0001551306-25-000006","form_type":"8-K","ticker":"PGNY","cik":"0001551306","company_name":"Progyny, Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.972215+00:00","generated_at":"2026-05-28T03:16:59.037391+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"medium","headline":"Progyny expects Q4 2024 revenue, net income, Adjusted EBITDA slightly above prior guidance","bullets":["Company updates guidance at JPM Healthcare Conference; Q4 results expected slightly above November ranges.","Previous guidance assumed member activity flat to down vs Q3 2024; improved pacing drove the beat.","CEO Pete Anevski to present on Jan 14, 2025 at 7:30 a.m. PT; audiocast available on investor site.","No specific dollar amounts or revised ranges provided in the press release."],"urls":{"canonical":"https://secwatch.observer/filing/0001551306-25-000006","json":"https://secwatch.observer/filing/0001551306-25-000006.json","markdown":"https://secwatch.observer/filing/0001551306-25-000006.md","text":"https://secwatch.observer/filing/0001551306-25-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551306/000155130625000006/0001551306-25-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551306/000155130625000006/pgny-20250113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:16:59.037391+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}